Glutamine in the Prevention and Treatment of Mucositis in Adult Cancer Patients: a Systematic Review of Literature

Detalhes bibliográficos
Autor(a) principal: Miranda, Mariana Paes de
Data de Publicação: 2015
Outros Autores: Souza, Daiane Spitz de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/521
Resumo: Introduction: Currently, several studies have evaluated the impact of the use of glutamine during anti-cancer treatment because its depletion over time may be related to the aggravation of oral mucositis and of the gastrointestinal tract. Objective: This study aimed to perform a systematic review on the knowledge available in the literature about the use of glutamine in the prevention and treatment of mucositis in patients undergoing radiotherapy and chemoterapy. Method: Human clinical trials published between 2004 and 2014 were selected in the databases indexed in PubMed / MEDLINE and LILACS, with the following keywords: glutamine and radiotherapy, glutamine and cancer and mucositis, glutamine and chemotherapy, glutamine and mucositis. After preliminary analysis, six articles were selected according to the established eligibility criteria. Results: Regarding the dose, chemical form, amino acid administration time and classification of mucositis, studies have been heterogeneous. Four of the six reviewed articles found benefits to its use. No study found deleterious effects, but there was no evaluation as to the survival and progression of the disease. Conclusion: The use of glutamine in cancer treatment may be a viable option, especially with respect to the prevention of more serious degrees of mucositis. More clinical trials in humans are needed for a safe dosage if use is established, as well as studies to assess the impact on treatment response and survival of individuals.
id INCA-1_1dab590fe67d261d3e833168e0614ab3
oai_identifier_str oai:rbc.inca.gov.br:article/521
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Glutamine in the Prevention and Treatment of Mucositis in Adult Cancer Patients: a Systematic Review of LiteratureLa Glutamina en la Prevención y Tratamiento de la Mucositis en Pacientes Adultos con Cáncer: una Revisión Sistemática de la LiteraturaGlutamina na Prevenção e Tratamento da Mucosite em Pacientes Adultos Oncológicos: uma Revisão Sistemática da LiteraturaNeoplasiasGlutaminaMucositeRadioterapiaQuimioterapiaRevisãoNeoplasmsGlutamineMucositisRadiotherapyDrug TherapyReviewNeoplasiasGlutaminaMucositisRadioterapiaQuimioterapiaRevisiónIntroduction: Currently, several studies have evaluated the impact of the use of glutamine during anti-cancer treatment because its depletion over time may be related to the aggravation of oral mucositis and of the gastrointestinal tract. Objective: This study aimed to perform a systematic review on the knowledge available in the literature about the use of glutamine in the prevention and treatment of mucositis in patients undergoing radiotherapy and chemoterapy. Method: Human clinical trials published between 2004 and 2014 were selected in the databases indexed in PubMed / MEDLINE and LILACS, with the following keywords: glutamine and radiotherapy, glutamine and cancer and mucositis, glutamine and chemotherapy, glutamine and mucositis. After preliminary analysis, six articles were selected according to the established eligibility criteria. Results: Regarding the dose, chemical form, amino acid administration time and classification of mucositis, studies have been heterogeneous. Four of the six reviewed articles found benefits to its use. No study found deleterious effects, but there was no evaluation as to the survival and progression of the disease. Conclusion: The use of glutamine in cancer treatment may be a viable option, especially with respect to the prevention of more serious degrees of mucositis. More clinical trials in humans are needed for a safe dosage if use is established, as well as studies to assess the impact on treatment response and survival of individuals.Introducción: En la actualidad, varios estudios han evaluado el impacto de la utilización de glutamina durante el tratamiento contra el cáncer debido a su disminución a lo largo del tiempo puede estar relacionada con el empeoramiento de la mucositis oral y del tracto gastrointestinal. Objetivo: Este estudio tuvo como objetivo realizar una revisión sistemática de los conocimientos disponibles en la literatura sobre el uso de la glutamina en la prevención y tratamiento de la mucositis en pacientes sometidos a radioterapia y/o quimioterapia. Método: Se trata de una revisión sistemática de la literatura basada en la metodología del Instituto de Cochrane. Se seleccionaron los ensayos clínicos en adultos publicados entre 2004 y 2014 en las bases de datos indexadas en PubMed / MEDLINE y LILACS, con las siguientes palabras clave: glutamina y la radiación, la glutamina y el cáncer y mucositis, glutamina y quimioterapia, glutamina y mucositis. Después de un análisis preliminar, se seleccionaron seis artículos, de acuerdo con los criterios de elegibilidad establecidos. Resultados: En cuanto a la dosis, la forma química, amino ácido y tiempo de administración clasificación de la mucositis, los estudios se muestran heterogéneos, cuatro de los seis artículos revisados encontraron beneficios de su uso. Ningún estudio encontró efectos deletéreos, pero no había ninguna evaluación en cuanto a la progresión de la supervivencia y la enfermedad. Conclusión: El uso de la glutamina en el tratamiento del cáncer puede ser una opción viable, especialmente con respecto a la prevención de grados más graves de la mucositis. Se necesitan más ensayos clínicos en humanos para que se establezca una dosis segura de uso, así como los estudios para evaluar el impacto en la respuesta al tratamiento y la supervivencia de los individuos.Introdução: Atualmente, diversos estudos têm avaliado o impacto do uso da glutamina durante o tratamento antineoplásico, pois sua depleção ao longo do tempo pode estar relacionada ao agravamento da mucosite oral e do trato gastrointestinal. Objetivo: O presente trabalho teve como objetivo realizar uma revisão sistemática sobre os conhecimentos disponíveis acerca da utilização da glutamina na prevenção e tratamento da mucosite em pacientes submetidos à radioterapia e/ou quimioterapia. Método: Trata-se de uma revisão sistemática da literatura baseada na metodologia do Instituto Cochrane. Foram selecionados ensaios clínicos em indivíduos adultos, publicados entre 2004 e 2014, nas bases de dados da MEDLINE e LILACS por meio do Pubmed, com os seguintes descritores: glutamina e radioterapia, glutamina e câncer e mucosite, glutamina e quimioterapia, glutamina e mucosite. Após análise prévia, seis artigos foram selecionados de acordo com os critérios estabelecidos. Resultados: Com relação à dose, forma química, tempo de administração do aminoácido e classificação da mucosite, os estudos se mostraram heterogêneos. Quatro, dos seis artigos avaliados, encontraram benefícios ao seu uso. Nenhum estudo encontrou efeitos deletérios, mas não houve avaliação quanto à sobrevida e à progressão de doença. Conclusão: A utilização da glutamina no tratamento oncológico pode ser uma opção viável, principalmente com relação à prevenção de graus mais graves de mucosite. Mais ensaios clínicos em humanos são necessários, para que seja estabelecida uma dosagem segura de utilização, bem como estudos que avaliem o impacto na resposta ao tratamento e na sobrevida dos indivíduos.INCA2015-09-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionRevisão de literaturaapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/52110.32635/2176-9745.RBC.2015v61n3.521Revista Brasileira de Cancerologia; Vol. 61 No. 3 (2015): July/Aug./Sept.; 277-285Revista Brasileira de Cancerologia; Vol. 61 Núm. 3 (2015): jul./agosto/sept.; 277-285Revista Brasileira de Cancerologia; v. 61 n. 3 (2015): jul./ago./set.; 277-2852176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/521/316Miranda, Mariana Paes deSouza, Daiane Spitz deinfo:eu-repo/semantics/openAccess2021-11-29T20:08:24Zoai:rbc.inca.gov.br:article/521Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T20:08:24Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Glutamine in the Prevention and Treatment of Mucositis in Adult Cancer Patients: a Systematic Review of Literature
La Glutamina en la Prevención y Tratamiento de la Mucositis en Pacientes Adultos con Cáncer: una Revisión Sistemática de la Literatura
Glutamina na Prevenção e Tratamento da Mucosite em Pacientes Adultos Oncológicos: uma Revisão Sistemática da Literatura
title Glutamine in the Prevention and Treatment of Mucositis in Adult Cancer Patients: a Systematic Review of Literature
spellingShingle Glutamine in the Prevention and Treatment of Mucositis in Adult Cancer Patients: a Systematic Review of Literature
Miranda, Mariana Paes de
Neoplasias
Glutamina
Mucosite
Radioterapia
Quimioterapia
Revisão
Neoplasms
Glutamine
Mucositis
Radiotherapy
Drug Therapy
Review
Neoplasias
Glutamina
Mucositis
Radioterapia
Quimioterapia
Revisión
title_short Glutamine in the Prevention and Treatment of Mucositis in Adult Cancer Patients: a Systematic Review of Literature
title_full Glutamine in the Prevention and Treatment of Mucositis in Adult Cancer Patients: a Systematic Review of Literature
title_fullStr Glutamine in the Prevention and Treatment of Mucositis in Adult Cancer Patients: a Systematic Review of Literature
title_full_unstemmed Glutamine in the Prevention and Treatment of Mucositis in Adult Cancer Patients: a Systematic Review of Literature
title_sort Glutamine in the Prevention and Treatment of Mucositis in Adult Cancer Patients: a Systematic Review of Literature
author Miranda, Mariana Paes de
author_facet Miranda, Mariana Paes de
Souza, Daiane Spitz de
author_role author
author2 Souza, Daiane Spitz de
author2_role author
dc.contributor.author.fl_str_mv Miranda, Mariana Paes de
Souza, Daiane Spitz de
dc.subject.por.fl_str_mv Neoplasias
Glutamina
Mucosite
Radioterapia
Quimioterapia
Revisão
Neoplasms
Glutamine
Mucositis
Radiotherapy
Drug Therapy
Review
Neoplasias
Glutamina
Mucositis
Radioterapia
Quimioterapia
Revisión
topic Neoplasias
Glutamina
Mucosite
Radioterapia
Quimioterapia
Revisão
Neoplasms
Glutamine
Mucositis
Radiotherapy
Drug Therapy
Review
Neoplasias
Glutamina
Mucositis
Radioterapia
Quimioterapia
Revisión
description Introduction: Currently, several studies have evaluated the impact of the use of glutamine during anti-cancer treatment because its depletion over time may be related to the aggravation of oral mucositis and of the gastrointestinal tract. Objective: This study aimed to perform a systematic review on the knowledge available in the literature about the use of glutamine in the prevention and treatment of mucositis in patients undergoing radiotherapy and chemoterapy. Method: Human clinical trials published between 2004 and 2014 were selected in the databases indexed in PubMed / MEDLINE and LILACS, with the following keywords: glutamine and radiotherapy, glutamine and cancer and mucositis, glutamine and chemotherapy, glutamine and mucositis. After preliminary analysis, six articles were selected according to the established eligibility criteria. Results: Regarding the dose, chemical form, amino acid administration time and classification of mucositis, studies have been heterogeneous. Four of the six reviewed articles found benefits to its use. No study found deleterious effects, but there was no evaluation as to the survival and progression of the disease. Conclusion: The use of glutamine in cancer treatment may be a viable option, especially with respect to the prevention of more serious degrees of mucositis. More clinical trials in humans are needed for a safe dosage if use is established, as well as studies to assess the impact on treatment response and survival of individuals.
publishDate 2015
dc.date.none.fl_str_mv 2015-09-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Revisão de literatura
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/521
10.32635/2176-9745.RBC.2015v61n3.521
url https://rbc.inca.gov.br/index.php/revista/article/view/521
identifier_str_mv 10.32635/2176-9745.RBC.2015v61n3.521
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/521/316
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 61 No. 3 (2015): July/Aug./Sept.; 277-285
Revista Brasileira de Cancerologia; Vol. 61 Núm. 3 (2015): jul./agosto/sept.; 277-285
Revista Brasileira de Cancerologia; v. 61 n. 3 (2015): jul./ago./set.; 277-285
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042244421681152